Ray Dalio Trans Medics Group, Inc. Transaction History
Bridgewater Associates, LP
- $21.1 Billion
- Q4 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 3,463 shares of TMDX stock, worth $300,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,463
Previous 4,872
28.92%
Holding current value
$300,726
Previous $764,000
71.86%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TMDX
# of Institutions
343Shares Held
30.4MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$316 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$230 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$118 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$86.9 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$86.2 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.76B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...